Flagship VentureLabs V Manager LLC's Net Worth
$197 Million
Who is Flagship VentureLabs V Manager LLC?
Flagship VentureLabs V Manager LLC has an estimated net worth of $197 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Kaleido Biosciences, Inc., Omega Therapeutics, Inc., Codiak BioSciences, Inc., and Evelo Biosciences, Inc..
SEC CIK
Flagship VentureLabs V Manager LLC's CIK is 0001768987
Past Insider Trading and Trends
2021 was Flagship VentureLabs V Manager LLC's most active year for acquiring shares with 13 total transactions. Flagship VentureLabs V Manager LLC's most active month to acquire stocks was the month of February. 2021 was Flagship VentureLabs V Manager LLC's most active year for disposing of shares, totalling 15 transactions. Flagship VentureLabs V Manager LLC's most active month to dispose stocks was the month of July. 2021 saw Flagship VentureLabs V Manager LLC paying a total of $19,999,973.00 for 57,944,228 shares, this is the most they've acquired in one year. In 2021 Flagship VentureLabs V Manager LLC cashed out on 119,347,583 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sana Biotechnology, Inc. (SANA) Snapshot price: $6.155
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.03% | -11.78M |
—
|
—
| 25M |
Sep 13
| |||
Form 4
|
∞
| 34.24M |
—
|
—
| 34.24M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.12% | 12M |
$15.00 | $13,999,995.00 | 37.48M |
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Codiak BioSciences, Inc. (CDAKQ) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Omega Therapeutics, Inc. (OMGA) Snapshot price: $3.585
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 23.71M |
$17.00 |
—
| 23.71M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |